Results 41 to 50 of about 42,071 (206)
BMJ, 2004 Although products for nicotine replacement therapy (NRT) have been available for over 20 years, they have been excluded until recently from state or insurance based health service provision in the United Kingdom and many other countries. They have therefore not been widely prescribed by doctors who help smokers wanting to quit.
openaire +3 more sources
Characteristics of selectors of nicotine replacement therapy [PDF]
Tobacco Control, 2005 Objective:To assess differences in demographic and smoking characteristics between smokers who have and have not used nicotine replacement therapy (NRT).Design:Mail survey of US smokers from a national research panel.Participants:Smokers 18 years and over who returned a survey on smoking (n = 9630).
S, Shiffman +2 more
openaire +2 more sources
Health Technology Assessment, 2020 Background: Smoking is the leading avoidable cause of illness and premature mortality. The first-line treatments for smoking cessation are nicotine replacement therapy and varenicline.
Neil M Davies +8 more
doaj +1 more source
The tobacco epidemic – pharmacological interventions for smoking cessation
Journal of Education, Health and Sport, 2023 Introduction: One of the biggest public health threats in the world is tobacco epidemic. According to WHO in the world cigarette smoking is the most common form of tobacco use.
Natalia Sergiel +9 more
doaj +1 more source
The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. [PDF]
, 2012 BACKGROUND: The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text ...
Cairns, John +5 more
core +2 more sources
Smoking cessation treatment in a real-life setting: the Greek experience
Therapeutic Advances in Respiratory Disease, 2007 Objectives: The aim of this study was to estimate the clinical efficacy of counseling combined with currently used pharmacotherapy for smoking cessation (bupropion SR and nicotine replacement therapy, NRT) in actual clinical practice, and to identify ...
Nikoletta Rovina +5 more
doaj +1 more source
Acute reduction in secretory immunoglobulin A following smoking cessation [PDF]
, 2004 Smokers report an increase in upper respiratory infections in the early phase of stopping smoking. One possible cause is a depletion in secretory immunoglobulin A (S-IgA) which has been observed in one study.
Clow, A +6 more
core +1 more source
What is the most effective nicotine replacement therapy? [PDF]
, 2003 No single nicotine replacement therapy is most effective for all smokers. All forms of nicotine replacement therapy (gum, transdermal patch, spray, inhaler, and lozenge) are equally effective, increasing smoking cessation rates by about 150% to 200%.
Diefenbach, Lisa J. +2 more
core
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. [PDF]
, 2017 Nicotine is metabolized into cotinine and then into trans-3'-hydroxycotinine, mainly by cytochrome P450 2A6. Recent studies reported better effectiveness of varenicline in women and in nicotine normal metabolizers phenotypically determined by nicotine ...
Cornuz, J. +6 more
core +2 more sources
What are the most effective ways you can help patients stop smoking? [PDF]
, 2008 Brief counseling, nicotine replacement therapy, antidepressants, and varenicline all work well. Physician intervention should begin with routine assessment of smoking status for all patients.
Mayo, Helen G. +2 more
core